FT Health Discusses Findings From World Malaria Report, Features Interview With DNDi Executive Director
FT Health: Progress stalls in fight against malaria
The latest issue of the Financial Times’ weekly global health newsletter highlights findings from the World Malaria Report and features an interview with Bernard Pécoul, executive director of the Drugs for Neglected Diseases Initiative (DNDi), who discusses the recent E.U. regulatory approval of the initiative’s drug, fexinidazole, to treat sleeping sickness. The newsletter also provides a round-up of global health-related news stories (Jack/Dodd, 11/23).